Articles published by Can-Fite BioPharma Ltd.Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite to Submit IND for the Treatment of Pancreatic Cancer Patients with Namodenoson
June 13, 2023
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite Announces $7.5 Million Concurrent Registered Direct Offering and Private Placement
January 11, 2023
Via Business Wire
Tickers
CANF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|